Get started
VERICI DX PLC LS-,001VERICI DX PLC LS-,001VERICI DX PLC LS-,001

VERICI DX PLC LS-,001

No trades
See on Supercharts
Overview
Financials News Discussions Seasonals

63V chart


Full chart

63V upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪9.47 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0250 EUR
Net income (FY)
‪−8.10 M‬ EUR
Revenue (FY)
‪939.90 K‬ EUR
Shares float
‪222.08 M‬
Beta (1Y)
0.50

About VERICI DX PLC ORD GBP0.001


Sector
Health Services
Industry
Medical/Nursing Services
CEO
Sara Jane Barrington
Website
vericidx.com
Headquarters
Franklin
Founded
2020
ISIN
GB00BM8HZD43
FIGI
BBG00Y48YQF2
Verici Dx Plc operates as a developer of advanced clinical diagnostics in organ transplant. It offers the following products for clinical validation and commercialization: Clarava and Tuteva. The Clarava product is a pre-transplant prognosis for the risk of early acute rejection. The Tuteva product is a post-transplant diagnostic focused upon acute cellular rejection, including sub-clinical rejection not being diagnosed through the current standard of care of rising serum creatinine levels. The company was founded on April 22, 2020 and is headquartered in Franklin, TN.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

63V news



Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange VERICI DX PLC LS-,001 stocks are traded under the ticker 63V.
63V reached its all-time high on Feb 10, 2021 with the price of 1.0400 EUR, and its all-time low was 0.0265 EUR and was reached on Dec 27, 2024. View more price dynamics on 63V chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track VERICI DX PLC LS-,001 financials in yearly and quarterly reports right on TradingView.
VERICI DX PLC LS-,001 is going to release the next earnings report on Apr 9, 2025. Keep track of upcoming events with our Earnings Calendar.
63V net income for the last half-year is ‪−1.26 M‬ EUR, while the previous report showed ‪−3.19 M‬ EUR of net income which accounts for 60.51% change. Track more VERICI DX PLC LS-,001 financial stats to get the full picture.
No, 63V doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VERICI DX PLC LS-,001 EBITDA is ‪−3.94 M‬ EUR, and current EBITDA margin is −766.63%. See more stats in VERICI DX PLC LS-,001 financial statements.
Like other stocks, 63V shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VERICI DX PLC LS-,001 stock right from TradingView charts — choose your broker and connect to your account.